SEC Form 4 · accession 0001209191-16-107117
Adamas Pharmaceuticals Inc · ADMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory T Went
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Mar 4, 2016
Accepted (ET)
Mar 8, 2016 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2016 | A | 28,750 | $13.66 | A | 58,758 | D | |
| Common Stock | holding | — | — | — | 390,792 | I | Gregory T Went & Marjorie S Went ttees Went Family Living Trust dtd 03/24/11 | |
| Common Stock | holding | — | — | — | 80,000 | I | Gregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Bridget Elise Went | |
| Common Stock | holding | — | — | — | 80,000 | I | Gregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Cora Margaret Went |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $13.66 | Mar 4, 2016 | A | 172,500 | A | — | Mar 3, 2026 | Common Stock | 172,500 | 172,500 | D |
Explanation of responses
- F1The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest annually on the applicable Vesting Date (as defined below) that is the same calendar quarter as each anniversary of the Reporting Person's date of grant, until the Restricted Stock Units are fully vested, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date. The applicable Vesting Date shall be the 20th of the last month of each calendar quarter in the following year(s) in which the original date of grant occurs. Accordingly, 25% shall vest on March 20, 2017, and each year thereafter.
- F2The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2016, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date. This option does not permit early exercise.